Silvia Taylor's guest appearances

Silvia Taylor

The PRovoke Media Podcast

Heather du Plessis-Allan Drive

Covid Watch

Prince Andrew

Chris Edwards

Nick Wilson

Dan Mitchinson

Steven Dromgool

Terry Taylor

Chand Sahrawat

John Carter

Steve Smith

Jack Tame

Gerry Brownlee

Peter Boshier

Shane Reti

Hannah McQueen

Patrick Gower

OwlTail

Another weapon in our arsenal to fight Covid-19.Medsafe has granted provisional approval for the Novavax vaccine Nuvaxovid.It will join Pfizer and AstraZeneca to be the third vaccine approved by MedSafe.Cabinet is yet to give final approval.Novavax Vice-President Silvia Taylor told Heather du Plessis-Allan people trust their vaccine as it uses protein-based technology.“We are finding that there is a sizeable part of the population around the world that is waiting for our vaccine, so we’re very excited about having it authorised in New Zealand.”LISTEN ABOVE

Another weapon in our arsenal to fight Covid-19. Medsafe has granted provisional approval for the Novavax vaccine Nuvaxovid. It will join Pfizer and AstraZeneca to be the third vaccine approved by MedSafe. Cabinet is yet to give final approval. Novavax Vice-President Silvia Taylor told Heather du Plessis-Allan people trust their vaccine as it uses protein-based technology. “We are finding that there is a sizeable part of the population around the world that is waiting for our vaccine, so we’re very excited about having it authorised in New Zealand.” LISTEN ABOVE

Silvia Taylor: Novavax Vice-President says people trust their vaccine as it uses protein-based technology

Another weapon in our arsenal to fight Covid-19.Medsafe has granted provisional approval for the Novavax vaccine Nuvaxovid.It will join Pfizer and AstraZeneca to be the third vaccine approved by MedSafe.Cabinet is yet to give final approval.Novavax Vice-President Silvia Taylor told Heather du Plessis-Allan people trust their vaccine as it uses protein-based technology.“We are finding that there is a sizeable part of the population around the world that is waiting for our vaccine, so we’re very excited about having it authorised in New Zealand.”LISTEN ABOVESee omnystudio.com/listener for privacy information.

Another weapon in our arsenal to fight Covid-19. Medsafe has granted provisional approval for the Novavax vaccine Nuvaxovid. It will join Pfizer and AstraZeneca to be the third vaccine approved by MedSafe. Cabinet is yet to give final approval. Novavax Vice-President Silvia Taylor told Heather du Plessis-Allan people trust their vaccine as it uses protein-based technology. “We are finding that there is a sizeable part of the population around the world that is waiting for our vaccine, so we’re very excited about having it authorised in New Zealand.” LISTEN ABOVESee <a href="https://omnystudio.com/listener" rel="nofollow" target="_blank">omnystudio.com/listener</a> for privacy information.

Adam Hildreth

In this episode, Paul Holmes talks to Silvia Taylor, SVP of corporate affairs at Novavax, and Adam Hildreth, founder/CEO of Crisp, about the reputation issues facing the pharmaceutical industry as the largest vaccine effort in the world rolls out to combat Covid-19. The group also addresses the disinformation Novavax had to deal with as part of their clinical trials and how the global pandemic has accelerated the urgency for transparency and humanity in healthcare communications.  

In this episode, Paul Holmes talks to Silvia Taylor, SVP of corporate affairs at Novavax, and Adam Hildreth, founder/CEO of Crisp, about the reputation issues facing the pharmaceutical industry as the largest vaccine effort in the world rolls out to combat Covid-19. The group also addresses the disinformation Novavax had to deal with as part of their clinical trials and how the global pandemic has accelerated the urgency for transparency and humanity in healthcare communications.

Vaccine Confidence with Novavax's Silvia Taylor and Crisp's Adam Hildreth